Nanotechnology for mesenchymal stem cell therapies

Journal of Controlled Release

Volumn 240, Issue , 2016, Pages 242-250

  Corradetti, Bruna ^a,b   Ferrari, Mauro ^b,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cell therapy; Mesenchymal stem cells; Nanotechnology; Regenerative medicine; Stem cell niche; Tissue engineering

Indexed keywords

CELL CULTURE; CELLS; CYTOLOGY; DIAGNOSIS; NANOTECHNOLOGY; STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

BIOACTIVE MOLECULES; CELL THERAPY; DIAGNOSTIC IMAGING SYSTEMS; LONG-TERM MAINTENANCES; MESENCHYMAL STEM CELL; POTENTIAL IMPACTS; REGENERATIVE MEDICINE; STEM-CELL NICHES;

CELL ENGINEERING;

NANOCARRIER; NANOMATERIAL;

ARTICLE; CELL ENGINEERING; CELL FATE; CELL LABELING; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED DRUG RELEASE; CYTOTOXICITY; DIAGNOSTIC IMAGING; GENETIC ENGINEERING; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NANOTECHNOLOGY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL NICHE; ANIMAL; CLINICAL TRIAL (TOPIC); INFLAMMATION; METABOLISM; PROCEDURES; TISSUE ENGINEERING; TRENDS;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NANOTECHNOLOGY; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84954290316     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.042     Document Type: Article

References (149)

1. [1] Watt, F.M., Huck, W.T., Role of the extracellular matrix in regulating stem cell fate. Nat. Rev. Mol. Cell Biol. 14 (2013), 467–473.
2. [2] Civin, C.I., Stem cell research: back to the future. Stem Cells 19 (2001), 356–357.
3. [3] Lovell-Badge, R., The future for stem cell research. Nature 414 (2001), 88–91.
4. [4] Kolios, G., Moodley, Y., Introduction to stem cells and regenerative medicine. Respiration 85 (2013), 3–10.
5. [5] Conley, B.J., Young, J.C., Trounson, A.O., Mollard, R., Derivation, propagation and differentiation of human embryonic stem cells. Int. J. Biochem. Cell Biol. 36 (2004), 555–567.
6. [6] Eckfeldt, C.E., Mendenhall, E.M., Verfaillie, C.M., The molecular repertoire of the ‘almighty’ stem cell. Nat. Rev. Mol. Cell Biol. 6 (2005), 726–737.
7. [7] Augello, A., Kurth, T.B., De Bari, C., Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur. Cell. Mater. 20 (2010), 121–133.
8. [8] de Wert, G., Mummery, C., Human embryonic stem cells: research, ethics and policy. Hum. Reprod. 18 (2003), 672–682.
9. [9] Ben-David, U., Benvenisty, N., The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11 (2011), 268–277.
10. [10] Dameshek, W., Bone marrow transplantation; a present-day challenge. Blood 12 (1957), 321–323.
11. [11] de la Morena, M.T., Gatti, R.A., A history of bone marrow transplantation. Immunol. Allergy Clin. N. Am. 30 (2010), 1–15.
12. [12] Xi, J., Zhang, S.C., Stem cells in development of therapeutics for Parkinson's disease: a perspective. J. Cell. Biochem. 105 (2008), 1153–1160.
13. [13] Magga, J., Savchenko, E., Malm, T., Rolova, T., Pollari, E., Valonen, P., Lehtonen, S., Jantunen, E., Aarnio, J., Lehenkari, P., Koistinaho, M., Muona, A., Koistinaho, J., Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer's disease. J. Cell. Mol. Med. 16 (2012), 1060–1073.
14. [14] Perin, E.C., Silva, G.V., Zheng, Y., Gahremanpour, A., Canales, J., Patel, D., Fernandes, M.R., Keller, L.H., Quan, X., Coulter, S.A., Moore, W.H., Herlihy, J.P., Willerson, J.T., Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase—bright stem cells in patients with ischemic heart failure. Am. Heart J. 163 (2012), 415–421 (.e411).
15. [15] Cerletti, M., Jurga, S., Witczak, C.A., Hirshman, M.F., Shadrach, J.L., Goodyear, L.J., Wagers, A.J., Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134 (2008), 37–47.
16. [16] Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D., Prockop, D.J., Stem cells and cell therapies in lung biology and lung diseases. Proc. Am. Thorac. Soc. 8 (2011), 223–272.
17. [17] Rashid, S.T., Corbineau, S., Hannan, N., Marciniak, S.J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., Semple, R., Weber, A., Lomas, D.A., Vallier, L., Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120 (2010), 3127–3136.
18. [18] Lange-Consiglio, A., Corradetti, B., Bizzaro, D., Magatti, M., Ressel, L., Tassan, S., Parolini, O., Cremonesi, F., Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane. J. Tissue Eng. Regen. Med. 6 (2012), 622–635.
19. [19] Casiraghi, F., Remuzzi, G., Abbate, M., Perico, N., Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev. 9 (2013), 65–79.
20. [20] Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., Tetta, C., Camussi, G., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20 (2009), 1053–1067.
21. [21] Berardis, S., Dwisthi Sattwika, P., Najimi, M., Sokal, E.M., Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. World J. Gastroenterol. 21 (2015), 742–758.
22. [22] Anthony, D.F., Shiels, P.G., Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs. Transplant. Res., 2, 2013, 10.
23. [23] Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R.G., Kobayashi, N., Yarmush, M.L., Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 19 (2010), 667–679.
24. [24] Corradetti, B., Correani, A., Romaldini, A., Marini, M.G., Bizzaro, D., Perrini, C., Cremonesi, F., Lange-Consiglio, A., Amniotic membrane-derived mesenchymal cells and their conditioned media: potential candidates for uterine regenerative therapy in the horse. PLoS One, 9, 2014, e111324.
25. [25] Bi, B., Schmitt, R., Israilova, M., Nishio, H., Cantley, L.G., Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18 (2007), 2486–2496.
26. [26] Gnecchi, M., He, H., Noiseux, N., Liang, O.D., Zhang, L., Morello, F., Mu, H., Melo, L.G., Pratt, R.E., Ingwall, J.S., Dzau, V.J., Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20 (2006), 661–669.
27. [27] Timmers, L., Lim, S.K., Arslan, F., Armstrong, J.S., Hoefer, I.E., Doevendans, P.A., Piek, J.J., El Oakley, R.M., Choo, A., Lee, C.N., Pasterkamp, G., de Kleijn, D.P., Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1 (2007), 129–137.
28. [28] Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., Westenfelder, C., Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Ren. Physiol. 289 (2005), F31–F42.
29. [29] Lange-Consiglio, A., Tassan, S., Corradetti, B., Meucci, A., Perego, R., Bizzaro, D., Cremonesi, F., Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries. Cytotherapy 15 (2013), 1011–1020.
30. [30] Quertainmont, R., Cantinieaux, D., Botman, O., Sid, S., Schoenen, J., Franzen, R., Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One, 7, 2012, e39500.
31. [31] Bokara, K.K., Oggu, G.S., Vidyasagar, A.J., Asthana, A., Lee, J.E., Rao Ch, M., Modulation of stem cell differentiation by the influence of nanobiomaterials/carriers. Curr. Stem Cell Res. Ther. 9 (2014), 458–468.
32. [32] Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
33. [33] Joshi, A., Punyani, S., Bale, S.S., Yang, H., Borca-Tasciuc, T., Kane, R.S., Nanotube-assisted protein deactivation. Nat. Nanotechnol. 3 (2008), 41–45.
34. [34] Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., Nann, T., Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 5 (2008), 763–775.
35. [35] Dzenis, Y., Material science. Spinning continuous fibers for nanotechnology. Science 304 (2004), 1917–1919.
36. [36] Gholizadeh-Ghaleh Aziz, S., Gholizadeh-Ghaleh Aziz, S., Akbarzadeh, A., The potential of nanofibers in tissue engineering and stem cell therapy. Artif. Cells Nanomed. Biotechnol., 2015, 1–6.
37. [37] Bettinger, C.J., Langer, R., Borenstein, J.T., Engineering substrate topography at the micro- and nanoscale to control cell function. Angew. Chem. Int. Ed. Engl. 48 (2009), 5406–5415.
38. [38] Ferrari, M., Nanovector therapeutics. Curr. Opin. Chem. Biol. 9 (2005), 343–346.
39. [39] Ferrari, M., Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 5 (2005), 161–171.
40. [40] Dresser, R., Building an ethical foundation for first-in-human nanotrials. J. Law Med. Ethics 40 (2012), 802–808.
41. [41] Peerani, R., Xandstra, P.W., Enabling stem cell therapies through synthetic stem cell–niche engineering. J. Clin. Invest. 120 (2010), 60–70.
42. [42] Corradetti, B., Taraballi, F., Powell, S., Sung, D., Minardi, S., Ferrari, M., Weiner, B.K., Tasciotti, E., Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem Cells Dev. 24 (2015), 1112–1123.
43. [43] Lane, S.W., Williams, D.A., Watt, F.M., Modulating the stem cell niche for tissue regeneration. Nat. Biotechnol. 32 (2014), 795–803.
44. [44] Ferreira, L., Karp, J.M., Nobre, L., Langer, R., New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3 (2008), 136–146.
45. [45] Choi, Y.C., Choi, J.S., Woo, C.H., Cho, Y.W., Stem cell delivery systems inspired by tissue-specific niches. J. Control. Release 193 (2014), 42–50.
46. [46] Voog, J., Jones, D.L., Stem cells and the niche: a dynamic duo. Cell Stem Cell 6 (2010), 103–115.
47. [47] Chen, L., Qiu, R., Li, L., The role of nanotechnology in induced pluripotent and embryonic stem cells research. J. Biomed. Nanotechnol. 10 (2014), 3431–3461.
48. [48] Sedaghati, T., Seifalian, A.M., Nanotechnology and bio-functionalisation for peripheral nerve regeneration. Neural Regen. Res. 10 (2015), 1191–1194.
49. [49] Mallapragada, S.K., Brenza, T.M., McMillan, J.M., Narasimhan, B., Sakaguchi, D.S., Sharma, A.D., Zbarska, S., Gendelman, H.E., Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines. Nanomedicine 11 (2015), 715–729.
50. [50] Lu, J., Aggarwal, R., Pompili, V.J., Das, H., A novel technology for hematopoietic stem cell expansion using combination of nanofiber and growth factors. Recent Pat. Nanotechnol. 4 (2010), 125–135.
51. [51] Kobolak, J., Dinnyes, A., Memic, A., Khademhosseini, A., Mobasheri, A., Mesenchymal stem cells: identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods, 2015, 10.1016/j.ymeth.2015.09.016.
52. [52] Duffy, C.R., Zhang, R., How, S.E., Lilienkampf, A., De Sousa, P.A., Bradley, M., Long term mesenchymal stem cell culture on a defined synthetic substrate with enzyme free passaging. Biomaterials 35 (2014), 5998–6005.
53. [53] Kim, E.S., Ahn, E.H., Dvir, T., Kim, D.H., Emerging nanotechnology approaches in tissue engineering and regenerative medicine. Int. J. Nanomedicine 9:Suppl. 1 (2014), 1–5.
54. [54] Park, J.S., Suryaprakash, S., Lao, Y.H., Leong, K.W., Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 84 (2015), 3–16.
55. [55] Corradetti, B., Freile, P., Pells, S., Bagnaninchi, P., Park, J., Fahmy, T.M., de Sousa, P.A., Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles. Biomaterials 33 (2012), 6634–6643.
56. [56] Levy, I., Sher, I., Corem-Salkmon, E., Ziv-Polat, O., Meir, A., Treves, A.J., Nagler, A., Kalter-Leibovici, O., Margel, S., Rotenstreich, Y., Bioactive magnetic near Infra-Red fluorescent core–shell iron oxide/human serum albumin nanoparticles for controlled release of growth factors for augmentation of human mesenchymal stem cell growth and differentiation. J. Nanobiotechnol., 13, 2015, 34.
57. [57] Lim, S.M., Oh, S.H., Lee, H.H., Yuk, S.H., Im, G.I., Lee, J.H., Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering. J. Mater. Sci. Mater. Med. 21 (2010), 2593–2600.
58. [58] Gokce, A., Yilmaz, I., Bircan, R., Tonbul, M., Gokay, N.S., Gokce, C., Synergistic effect of TGF-beta1 and BMP-7 on chondrogenesis and extracellular matrix synthesis: an in vitro study. Open Orthop. J. 6 (2012), 406–413.
59. [59] Ertan, A.B., Yilgor, P., Bayyurt, B., Calikoglu, A.C., Kaspar, C., Kok, F.N., Kose, G.T., Hasirci, V., Effect of double growth factor release on cartilage tissue engineering. J. Tissue Eng. Regen. Med. 7 (2013), 149–160.
60. [60] Zhou, X., Feng, W., Qiu, K., Chen, L., Wang, W., Nie, W., Mo, X., He, C., BMP-2 derived peptide and dexamethasone incorporated mesoporous silica nanoparticles for enhanced osteogenic differentiation of bone mesenchymal stem cells. ACS Appl. Mater. Interfaces 29 (2015), 15777–15789.
61. [61] Neumann, A., Christel, A., Kasper, C., Behrens, P., BMP2-loaded nanoporous silica nanoparticles promote osteogenic differentiation of human mesenchymal stem cells. RSC Adv., 3, 2013.
62. [62] Liu, D., He, X., Wang, K., He, C., Shi, H., Jian, L., Biocompatible silica nanoparticles–insulin conjugates for mesenchymal stem cell adipogenic differentiation. Bioconjug. Chem. 21 (2010), 1673–1684.
63. [63] Amin, H.D., Brady, M.A., St-Pierre, J.P., Stevens, M.M., Overby, D.R., Ethier, C.R., Stimulation of chondrogenic differentiation of adult human bone marrow-derived stromal cells by a moderate-strength static magnetic field. Tissue Eng. A 20 (2014), 1612–1620.
64. [64] Jing, D., Shen, G., Cai, J., Li, F., Huang, J., Wang, Y., Xu, Q., Tang, C., Luo, E., Effects of 180 mT static magnetic fields on diabetic wound healing in rats. Bioelectromagnetics 31 (2010), 640–648.
65. [65] Chiu, K.H., Ou, K.L., Lee, S.Y., Lin, C.T., Chang, W.J., Chen, C.C., Huang, H.M., Static magnetic fields promote osteoblast-like cells differentiation via increasing the membrane rigidity. Ann. Biomed. Eng. 35 (2007), 1932–1939.
66. [66] Mayer-Wagner, S., Passberger, A., Sievers, B., Aigner, J., Summer, B., Schiergens, T.S., Jansson, V., Muller, P.E., Effects of low frequency electromagnetic fields on the chondrogenic differentiation of human mesenchymal stem cells. Bioelectromagnetics 32 (2011), 283–290.
67. [67] De Mattei, M., Fini, M., Setti, S., Ongaro, A., Gemmati, D., Stabellini, G., Pellati, A., Caruso, A., Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields. Osteoarthr. Cartil. 15 (2007), 163–168.
68. [68] Son, B., Kim, H.D., Kim, M., Kim, J.A., Lee, J., Shin, H., Hwang, N.S., Park, T.H., Physical stimuli-induced chondrogenic differentiation of mesenchymal stem cells using magnetic nanoparticles. Adv. Healthc. Mater. 4 (2015), 1339–1347.
69. [69] Lima, J., Goncalves, A.I., Rodrigues, M.T., Reis, R.L., Gomes, M.E., The effect of magnetic stimulation on the osteogenic and chondrogenic differentiation of human stem cells derived from the adipose tissue. J. Magn. Magn. Mater. 292 (2015), 526–536.
70. [70] Ko, W.K., Heo, D.N., Moon, H.J., Lee, S.J., Bae, M.S., Lee, J.B., Sun, I.C., Jeon, H.B., Park, H.K., Kwon, I.K., The effect of gold nanoparticle size on osteogenic differentiation of adipose-derived stem cells. J. Colloid Interface Sci. 438 (2015), 68–76.
71. [71] Yi, C., Liu, D., Fong, C.C., Zhang, J., Yang, M., Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. ACS Nano 4 (2010), 6439–6448.
72. [72] Keselowsky, B.G., Collard, D.M., Garcia, A.J., Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 5953–5957.
73. [73] Li, J.J., Kawazoe, N., Chen, G., Gold nanoparticles with different charge and moiety induce differential cell response on mesenchymal stem cell osteogenesis. Biomaterials 54 (2015), 226–236.
74. [74] Nayerossadat, N., Maedeh, T., Ali, P.A., Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res., 1, 2012, 27.
75. [75] Guo, X., Huang, L., Recent advances in nonviral vectors for gene delivery. Acc. Chem. Res. 45 (2012), 971–979.
76. [76] Glover, D.J., Lipps, H.J., Jans, D.A., Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev. Genet. 6 (2005), 299–310.
77. [77] Chen, W., Tsai, P.H., Hung, Y., Chiou, S.H., Mou, C.Y., Nonviral cell labeling and differentiation agent for induced pluripotent stem cells based on mesoporous silica nanoparticles. ACS Nano 7 (2013), 8423–8440.
78. [78] Haleem-Smith, H., Derfoul, A., Okafor, C., Tuli, R., Olsen, D., Hall, D.J., Tuan, R.S., Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol. Biotechnol. 30 (2005), 9–20.
79. [79] Kim, J.H., Park, J.S., Yang, H.N., Woo, D.G., Jeon, S.Y., Do, H.J., Lim, H.Y., Kim, J.M., Park, K.H., The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis. Biomaterials 32 (2011), 268–278.
80. [80] Park, J.S., Yang, H.N., Woo, D.G., Jeon, S.Y., Do, H.J., Lim, H.Y., Kim, J.H., Park, K.H., Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles. Biomaterials 32 (2011), 3679–3688.
81. [81] Yang, H.N., Park, J.S., Woo, D.G., Jeon, S.Y., Do, H.J., Lim, H.Y., Kim, J.H., Park, K.H., C/EBP-alpha and C/EBP-beta-mediated adipogenesis of human mesenchymal stem cells (hMSCs) using PLGA nanoparticles complexed with poly(ethyleneimmine). Biomaterials 32 (2011), 5924–5933.
82. [82] Yue, J., Wu, J., Liu, D., Zhao, X., Lu, W.W., BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector. Nanoscale Res. Lett., 10, 2015, 203.
83. [83] Hsu, S.H., Ho, T.T., Tseng, T.C., Nanoparticle uptake and gene transfer efficiency for MSCs on chitosan and chitosan–hyaluronan substrates. Biomaterials 33 (2012), 3639–3650.
84. [84] Incani, V., Tunis, E., Clements, B.A., Olson, C., Kucharski, C., Lavasanifar, A., Uludag, H., Palmitic acid substitution on cationic polymers for effective delivery of plasmid DNA to bone marrow stromal cells. J. Biomed. Mater. Res. A 81 (2007), 493–504.
85. [85] Clements, B.A., Incani, V., Kucharski, C., Lavasanifar, A., Ritchie, B., Uludag, H., A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials 28 (2007), 4693–4704.
86. [86] Tseng, T.C., Hsu, S.H., Substrate-mediated nanoparticle/gene delivery to MSC spheroids and their applications in peripheral nerve regeneration. Biomaterials 35 (2014), 2630–2641.
87. [87] Kong, L., Alves, C.S., Hou, W., Qiu, J., Mohwald, H., Tomas, H., Shi, X., RGD peptide-modified dendrimer-entrapped gold nanoparticles enable highly efficient and specific gene delivery to stem cells. ACS Appl. Mater. Interfaces 7 (2015), 4833–4843.
88. [88] Gattazzo, F., Urciuolo, A., Bonaldo, P., Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim. Biophys. Acta 1840 (2014), 2506–2519.
89. [89] Dang, J.M., Leong, K.W., Myogenic induction of aligned mesenchymal stem cell sheets by culture on thermally responsive electrospun nanofibers. Adv. Mater. 19 (2007), 2775–2779.
90. [90] DuFort, C.C., Paszek, M.J., Weaver, V.M., Balancing forces: architectural control of mechanotransduction. Nat. Rev. Mol. Cell Biol. 12 (2011), 308–319.
91. [91] Wagers, A.J., The stem cell niche in regenerative medicine. Cell Stem Cell 10 (2012), 362–369.
92. [92] Greco, V., Guo, S., Compartmentalized organization: a common and required feature of stem cell niches?. Development 137 (2010), 1586–1594.
93. [93] Jones, D.L., Wagers, A.J., No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 9 (2008), 11–21.
94. [94] Minardi, S., Corradetti, B., Taraballi, F., Sandri, M., Van Eps, J., Cabrera, F.J., Weiner, B.K., Tampieri, A., Tasciotti, E., Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation. Biomaterials 62 (2015), 128–137.
95. [95] Mashinchian, O., Turner, L.A., Dalby, M.J., Laurent, S., Shokrgozar, M.A., Bonakdar, S., Imani, M., Mahmoudi, M., Regulation of stem cell fate by nanomaterial substrates. Nanomedicine (Lond.) 10 (2015), 829–847.
96. [96] Yim, E.K., Pang, S.W., Leong, K.W., Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp. Cell Res. 313 (2007), 1820–1829.
97. [97] Dalby, M.J., McCloy, D., Robertson, M., Wilkinson, C.D., Oreffo, R.O., Osteoprogenitor response to defined topographies with nanoscale depths. Biomaterials 27 (2006), 1306–1315.
98. [98] Dalby, M.J., Gadegaard, N., Curtis, A.S., Oreffo, R.O., Nanotopographical control of human osteoprogenitor differentiation. Curr. Stem Cell Res. Ther. 2 (2007), 129–138.
99. [99] Jahani, H., Kaviani, S., Hassanpour-Ezatti, M., Soleimani, M., Kaviani, Z., Zonoubi, Z., The effect of aligned and random electrospun fibrous scaffolds on rat mesenchymal stem cell proliferation. Cell J. 14 (2012), 31–38.
100. [100] Dalby, M.J., Gadegaard, N., Tare, R., Andar, A., Riehle, M.O., Herzyk, P., Wilkinson, C.D., Oreffo, R.O., The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat. Mater. 6 (2007), 997–1003.
101. [101] Abagnale, G., Steger, M., Nguyen, V.H., Hersch, N., Sechi, A., Joussen, S., Denecke, B., Merkel, R., Hoffmann, B., Dreser, A., Schnakenberg, U., Gillner, A., Wagner, W., Surface topography enhances differentiation of mesenchymal stem cells towards osteogenic and adipogenic lineages. Biomaterials 61 (2015), 316–326.
102. [102] Caballero, M., Pappa, A.K., Roden, K.S., Krochmal, D.J., van Aalst, J.A., Osteoinduction of umbilical cord and palate periosteum-derived mesenchymal stem cells on poly(lactic-co-glycolic) acid nanomicrofibers. Ann. Plast. Surg. 72 (2014), S176–S183.
103. [103] Li, W.J., Tuli, R., Huang, X., Laquerriere, P., Tuan, R.S., Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials 26 (2005), 5158–5166.
104. [104] Jia, L., Prabhakaran, M.P., Qin, X., Ramakrishna, S., Stem cell differentiation on electrospun nanofibrous substrates for vascular tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 33 (2013), 4640–4650.
105. [105] Bagher, Z., Azami, M., Ebrahimi-Barough, S., Mirzadeh, H., Solouk, A., Soleimani, M., Ai, J., Nourani, M.R., Joghataei, M.T., Differentiation of Wharton's jelly-derived mesenchymal stem cells into motor neuron-like cells on three-dimensional collagen-grafted nanofibers. Mol. Neurobiol., 2015, 1–12.
106. [106] Luo, Y., Shen, H., Fang, Y., Cao, Y., Huang, J., Zhang, M., Dai, J., Shi, X., Zhang, Z., Enhanced proliferation and osteogenic differentiation of mesenchymal stem cells on graphene oxide-incorporated electrospun poly(lactic-co-glycolic acid) nanofibrous mats. ACS Appl. Mater. Interfaces 7 (2015), 6331–6339.
107. [107] Ardeshirylajimi, A., Mossahebi-Mohammadi, M., Vakilian, S., Langroudi, L., Seyedjafari, E., Atashi, A., Soleimani, M., Comparison of osteogenic differentiation potential of human adult stem cells loaded on bioceramic-coated electrospun poly (L-lactide) nanofibres. Cell Prolif. 48 (2015), 47–58.
108. [108] Kai, D., Prabhakaran, M.P., Jin, G., Tian, L., Ramakrishna, S., Potential of VEGF-encapsulated electrospun nanofibers for in vitro cardiomyogenic differentiation of human mesenchymal stem cells. J. Tissue Eng. Regen. Med., 2015.
109. [109] Mathapati, S., Bishi, D.K., Venugopal, J.R., Cherian, K.M., Guhathakurta, S., Ramakrishna, S., Verma, R.S., Nanofibers coated on acellular tissue-engineered bovine pericardium supports differentiation of mesenchymal stem cells into endothelial cells for tissue engineering. Nanomedicine (London) 9 (2014), 623–634.
110. [110] Diaz-Gomez, L., Alvarez-Lorenzo, C., Concheiro, A., Silva, M., Dominguez, F., Sheikh, F.A., Cantu, T., Desai, R., Garcia, V.L., Macossay, J., Biodegradable electrospun nanofibers coated with platelet-rich plasma for cell adhesion and proliferation. Mater. Sci. Eng. C Mater. Biol. Appl. 40 (2014), 180–188.
111. [111] Kang, B.J., Kim, H., Lee, S.K., Kim, J., Shen, Y., Jung, S., Kang, K.S., Im, S.G., Lee, S.Y., Choi, M., Hwang, N.S., Cho, J.Y., Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function. Acta Biomater. 10 (2014), 3007–3017.
112. [112] Low, W.C., Rujitanaroj, P.O., Lee, D.K., Kuang, J., Messersmith, P.B., Chan, J.K., Chew, S.Y., Mussel-inspired modification of nanofibers for REST siRNA delivery: understanding the effects of gene-silencing and substrate topography on human mesenchymal stem cell neuronal commitment. Macromol. Biosci. 15:10 (2015), 1457–1468.
113. [113] Hwang, C.W., Johnston, P.V., Gerstenblith, G., Weiss, R.G., Tomaselli, G.F., Bogdan, V.E., Panigrahi, A., Leszczynska, A., Xia, Z., Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. Biomaterials 52 (2015), 318–326.
114. [114] Kai, D., Wang, Q.L., Wang, H.J., Prabhakaran, M.P., Zhang, Y., Tan, Y.Z., Ramakrishna, S., Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model. Acta Biomater. 10 (2014), 2727–2738.
115. [115] Sadhukha, T., Prabha, S., Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin. AAPS PharmSciTech 15 (2014), 1029–1038.
116. [116] Sadhukha, T., O'Brien, T.D., Prabha, S., Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. J. Control. Release 196 (2014), 243–251.
117. [117] Jo, J., Aoki, I., Tabata, Y., Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells. J. Control. Release 142 (2010), 465–473.
118. [118] Gao, Z., Zhang, L., Hu, J., Sun, Y., Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles. Nanomedicine 9 (2013), 174–184.
119. [119] Edmundson, M., Thanh, N.T., Song, B., Nanoparticles based stem cell tracking in regenerative medicine. Theranostics 3 (2013), 573–582.
120. [120] Accomasso, L., Cibrario Rocchietti, E., Raimondo, S., Catalano, F., Alberto, G., Giannitti, A., Minieri, V., Turinetto, V., Orlando, L., Saviozzi, S., Caputo, G., Geuna, S., Martra, G., Giachino, C., Fluorescent silica nanoparticles improve optical imaging of stem cells allowing direct discrimination between live and early-stage apoptotic cells. Small 8 (2012), 3192–3200.
121. [121] Huang, D.M., Hung, Y., Ko, B.S., Hsu, S.C., Chen, W.H., Chien, C.L., Tsai, C.P., Kuo, C.T., Kang, J.C., Yang, C.S., Mou, C.Y., Chen, Y.C., Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J. 19 (2005), 2014–2016.
122. [122] Jasmin, Torres, A.L., Jelicks, L., de Carvalho, A.C., Spray, D.C., Mendez-Otero, R., Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging. Methods Mol. Biol. 906 (2012), 239–252.
123. [123] Wang, Y., Xu, C., Ow, H., Commercial nanoparticles for stem cell labeling and tracking. Theranostics 3 (2013), 544–560.
124. [124] Bull, E., Madani, S.Y., Sheth, R., Seifalian, A., Green, M., Seifalian, A.M., Stem cell tracking using iron oxide nanoparticles. Int. J. Nanomedicine 9 (2014), 1641–1653.
125. [125] Qi, Y., Feng, G., Huang, Z., Yan, W., The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy. Mol. Biol. Rep. 40 (2013), 2733–2740.
126. [126] Arbab, A.S., Yocum, G.T., Kalish, H., Jordan, E.K., Anderson, S.A., Khakoo, A.Y., Read, E.J., Frank, J.A., Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104 (2004), 1217–1223.
127. [127] Lee, N., Hyeon, T., Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 41 (2012), 2575–2589.
128. [128] Li, L., Jiang, W., Luo, K., Song, H., Lan, F., Wu, Y., Gu, Z., Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics 3 (2013), 595–615.
129. [129] Delcroix, G.J., Jacquart, M., Lemaire, L., Sindji, L., Franconi, F., Le Jeune, J.J., Montero-Menei, C.N., Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res. 1255 (2009), 18–31.
130. [130] Jendelova, P., Herynek, V., Urdzikova, L., Glogarova, K., Kroupova, J., Andersson, B., Bryja, V., Burian, M., Hajek, M., Sykova, E., Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76 (2004), 232–243.
131. [131] Bourzac, C.A., Koenig, J.B., Link, K.A., Nykamp, S.G., Koch, T.G., Evaluation of ultrasmall superparamagnetic iron oxide contrast agent labeling of equine cord blood and bone marrow mesenchymal stromal cells. Am. J. Vet. Res. 75 (2014), 1010–1017.
132. [132] Yang, K., Xiang, P., Zhang, C., Zou, L., Wu, X., Gao, Y., Kang, Z., He, K., Liu, J., Peng, C., Magnetic resonance evaluation of transplanted mesenchymal stem cells after myocardial infarction in swine. Can. J. Cardiol. 27 (2011), 818–825.
133. [133] Li, G., Lee, D., Han, D., Rawall, B., Briley-Saeboe, K., Mani, V., Gillespie, V., Hajjar, R., Fayad, Z., Tadros, R., Faries, P., In vivo tracking and effects of SPIO-labeled mesenchymal stem cells in a porcine model of abdominal aortic aneurysm. FASEB J., 29, 2015.
134. [134] Scharf, A., Holmes, S., Thoresen, M., Mumaw, J., Stumpf, A., Peroni, J., Superparamagnetic iron oxide nanoparticles as a means to track mesenchymal stem cells in a large animal model of tendon injury. Contrast Media Mol. Imaging 10:5 (2015), 388–397.
135. [135] Yoo, J.H., Park, C., Jung, D.I., Lim, C.Y., Kang, B.T., Kim, J.H., Park, J.W., Kim, J.H., Park, H.M., In vivo cell tracking of canine allogenic mesenchymal stem cells administration via renal arterial catheterization and physiopathological effects on the kidney in two healthy dogs. J. Vet. Med. Sci. 73 (2011), 269–274.
136. [136] Hansen, L., Hansen, A.B., Mathiasen, A.B., Ng, M., Bhakoo, K., Ekblond, A., Kastrup, J., Friis, T., Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies. Scand. J. Clin. Lab. Invest. 74 (2014), 437–446.
137. [137] Roeder, E., Henrionnet, C., Goebel, J.C., Gambier, N., Beuf, O., Grenier, D., Chen, B., Vuissoz, P.A., Gillet, P., Pinzano, A., Dose–response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study. PLoS One, 9, 2014, e98451.
138. [138] Moraes, L., Vasconcelos-dos-Santos, A., Santana, F.C., Godoy, M.A., Rosado-de-Castro, P.H., Jasmin, Azevedo-Pereira, R.L., Cintra, W.M., Gasparetto, E.L., Santiago, M.F., Mendez-Otero, R., Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease. Stem Cell Res. 9 (2012), 143–155.
139. [139] Zhou, B., Li, D., Qian, J., Li, Z., Pang, P., Shan, H., MR tracking of SPIO-labeled mesenchymal stem cells in rats with liver fibrosis could not monitor the cells accurately. Contrast Media Mol. Imaging 10:6 (2015), 473–480.
140. [140] Li, Z., Fan, D., Xiong, D., Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Stem Investig., 2015, 2–6.
141. [141] Kim, S.W., Khang, D., Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency. Int. J. Nanomedicine 10 (2015), 3989–4008.
142. [142] Branco, M.C., Schneider, J.P., Self-assembling materials for therapeutic delivery. Acta Biomater. 5 (2009), 817–831.
143. [143] Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., Mizushima, Y., Mizushima, T., Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers. Biomacromolecules 11 (2010), 2700–2706.
144. [144] Li, L., Guan, Y., Liu, H., Hao, N., Liu, T., Meng, X., Fu, C., Li, Y., Qu, Q., Zhang, Y., Ji, S., Chen, L., Chen, D., Tang, F., Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5 (2011), 7462–7470.
145. [145] Sabin, K., Kikyo, N., Microvesicles as mediators of tissue regeneration. Transl. Res. 163 (2014), 286–295.
146. [146] Baglio, S.R., Rooijers, K., Koppers-Lalic, D., Verweij, F.J., Perez Lanzon, M., Zini, N., Naaijkens, B., Perut, F., Niessen, H.W., Baldini, N., Pegtel, D.M., Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res. Ther., 6, 2015, 127.
147. [147] Deasy, B.M., Anderson, J.E., Zelina, S., Regulatory issues in the therapeutic use of stem cells. Andrades, J.A., (eds.) Regenerative Medicine and Tissue Engineering, 2014, InTech.
148. [148] Burger, S.R., Current regulatory issues in cell and tissue therapy. Cytotherapy 5 (2003), 289–298.
149. [149] Bagchi, D., Bio-nanotechnology: A Revolution in Food, Biomedical, and Health Sciences. 2013, Wiley-Blackwell, Chichester, West Sussex; Ames, Iowa.